TIDES USA 2026

"TIDES USA: Oligonucleotide & Peptide Therapeutics is North America’s flagship scientific conference dedicated to accelerating the discovery, development, manufacturing and delivery of oligonucleotide, peptide, mRNA, and genome-editing therapeutics. Scheduled for May 11–14 2026 at the Hynes Convention Center in Boston, Massachusetts, this multi-day event offers a highly structured program of more than 200 presentations spread across five core tracks, covering areas from early discovery through CMC (chemistry, manufacturing and controls), to advanced delivery strategies for complex biomolecules. The meeting draws a global audience of scientists, researchers, executives and technology leaders focused on next-generation therapeutic modalities.

The 2026 agenda features a stellar lineup of confirmed keynote speakers from major pharmaceutical and biotech institutions, including Robert S. Langer, ScD (Massachusetts Institute of Technology), Kiran Musunuru, MD, PhD (University of Pennsylvania), and Anastasia Khvorova, PhD (UMass Chan Medical School). These thought leaders, alongside additional experts from Eli Lilly and Novo Nordisk, will address pioneering science, emerging challenges and real-world case studies in oligo, peptide and genome-based drug development. Attendees can also engage in interactive workshops, poster sessions and an exhibit hall showcasing industry innovations, offering rich opportunities for collaboration, networking and commercialization."